Bharat Biotech's Covaxin Trials On Kids Likely To Begin In June

Bharat Biotech on May 23 stated it would begin trials of its COVID-19 vaccine Covaxin on children from June. "Kids vaccine trials of Bharat Biotech may get the license in third quarter of this year," stated an official of the company. Besides, the vaccine-maker is also eyeing to increase Covaxin manufacturing capacity to 700Mn doses by 2021 end as "the government placed an advanced purchase order of Rs 1,500 crore".